Integrated PK/PD Modeling and Machine Learning to Support CNS Compound Selection
PK/PD Modeling for CNS drug development using Phoenix NLME and machine learning for better CNS…
CertaraMarch 26, 2026
Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis
This study evaluated the pharmacokinetics (PK) and pharmacokinetic–pharmacodynamic (PK–PD) relationship of clazakizumab, an anti–interleukin-6 (IL-6)…
Danielle PillsburyMarch 24, 2026
From Numbers to Narrative: Mastering the Art of PK Presentation
Master PK data reporting with a structured guide to presenting pharmacokinetic results clearly and turning…
CertaraMarch 20, 2026
What are Common Bioequivalence Study Mistakes?
Learn about the most common bioequivalence study mistakes drug developers make and the differences between…
CertaraMarch 20, 2026
Navigate GxP Compliance in the Cloud with Confidence
Master SaaS GxP compliance with risk-based computer system validation (CSV) aligned to GAMP 5, FDA,…
CertaraMarch 6, 2026
Understanding and Calculating Steady State Pharmacokinetics
Steady state pharmacokinetics can seem abstract and confusing. Read this blog to gain a better…
CertaraMarch 5, 2026
